Finance update

AI SummaryClose X

Trellus Health plc has secured a US$600,000 unsecured loan from its substantial shareholder, the Icahn School of Medicine at Mount Sinai, which will extend the company's cash runway to late January 2026 and support its commercial strategy. The loan is non-interest bearing for the first six months, after which it accrues 8% annual interest, payable in cash or new ordinary shares at a conversion price of 0.525 pence, with a cap preventing Mount Sinai from exceeding 29.9% of the company's issued share capital upon conversion. The company is also in advanced discussions for a potential equity fundraising to further extend its cash runway and continues to focus on securing commercial contracts with pharmaceutical companies and CROs, with illustrative contract values ranging from $150k to $1 million.

Disclaimer*

UK 100

Latest directors dealings